Overview
Metabolic syndrome is a clustering of interrelated cardiometabolic risk factors that together substantially raise the likelihood of type 2 diabetes and atherosclerotic cardiovascular disease. The defining components are central (abdominal) obesity, elevated blood pressure, raised fasting glucose, elevated triglycerides, and reduced HDL cholesterol, with insulin resistance and chronic low-grade inflammation regarded as central mechanisms linking adipose tissue dysfunction to systemic metabolic disturbance. Epidemiological investigation focuses on prevalence and determinants across occupational, clinical, and adolescent populations, including its frequency among patients receiving antipsychotic or antidepressant medication, where treatment-related metabolic effects compound underlying risk. Anthropometric indices of central obesity are evaluated as practical predictors of metabolic risk, reflecting the syndrome's grounding in body-fat distribution and adipose tissue physiology. Research also addresses molecular and familial contributions, such as combined hyperlipidemia, and overlap with related conditions including polycystic ovary syndrome and menopausal cardiovascular risk. A substantial line of work examines dietary and nutritional management, evaluating antioxidant micronutrients, specific foods, and supplements for their effects on insulin sensitivity, lipid and glucose handling, and postprandial metabolism. Because its components are modifiable, metabolic syndrome is approached as a target for early identification and combined lifestyle and pharmacological intervention to prevent progression to overt disease.
Research published in this journal
12 peer-reviewed articles, ranked by relevance. Each links to its DOI.
Analysis of Effects of Kale Powder Consumption among Subjects with Potential Metabolic Syndrome: A Prospective Single-Arm Clinical Study
Prevalence and Determinants of Metabolic Syndrome in Schizophrenia Patients Treated with Antipsychotics Medications
Anti-Depression Medication Taking and Risk of Metabolic Syndrome among US Citizens Aged 60+ years: an Across-sectional Analysis of the NHANES 2007-2008
The Potentials of Antioxidant Micronutrients in the Management of Metabolic Syndrome
Molecular and Metabolic Pathogenesis of Familial Combined Hyperlipidemia and Association with Metabolic Syndrome
Predictive Value of Some Central Obesity Anthropometric Indicators to Metabolic Risk Factors in Syrian Adolescents
Evaluation of Cinnamon Supplementation on Insulin Resistance, BMI and Estradiol Levels in Women with Polycystic Ovary Syndrome: A Double-Blinded Randomized Controlled Clinical Trial
Cardiovascular Disease and Depression/Anxiety, Two Complication of Menopause Status
The Impact of Nutrients on Diabetes
Understanding the Physiology of Adipose Tissue: A Key to Combat Obesity?
Acute Effects of White Button and Shiitake Mushroom Powder Supplementation on Postprandial Lipemia and Glycemia Following a High-Fat Meal
How this research is being cited
The 12 articles above have been cited 24 times in the scholarly literature. Citation data via OpenAlex and Crossref, updated Jun 2026.
-
2026 · International Immunopharmacology
-
2025 · Gaziantep Üniversitesi Spor Bilimleri Dergisi
-
2025 · NMO Journal
-
2024 · Nutrients
-
2024 · Indian Journal of Animal Research
-
2024 · Frontiers in Nutrition
-
D. Aldisi et al. · 2024 · Frontiers in Nutrition
-
H. Sharebiani et al. · 2024 · Nutrients
A sample of recent works citing this journal's research on Metabolic Syndrome, linking to each citing work.